Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial

American Heart Journal

Volumn 138, Issue 2 I, 1999, Pages 247-253

  Oliva, F ^a   Latini, R ^a   Politi, A ^a   Staszewsky, L ^a   Maggioni, A P ^a   Nicolis, E ^a   Mauri, F ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; FUROSEMIDE; NITRATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEALTH CARE COST; HEART FUNCTION TEST; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

EID: 0032776403     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70108-0     Document Type: Article

References (21)

1. O' Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for different approach. J Heart Lung Transplant 1993;13:S107-12.
2. Stevenson LW, Couper G, Netterson B, et al. Target heart failure populations for newer therapies. Circulation 1995;92:S174-81.
3. Costanzo MR, Augustine S, Bourge R, et Al. Selection and treatment of candidates for heart transplantation: a statement for health professionals from the committee on heart failure and cardiac transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1995;92:3593-612.
4. Evans RW, Manninen DL, Dong FB. The National Heart Transplant Study: final report. Seattle, Wash: Battelle Human Affairs Research Centers; 1991.
5. Di Bianco R, Shabetai R, Kostuk W, et al. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989;320:677-83.
6. Uretsky BF, Jessup M, Konstam MA, et al. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure: lack of benefit compared with placebo. Circulation 1990;82:774-80.
7. Feldman AM, Bristow MR, Parmley WW, et al. Effects of vesnarinone on morbidity and mortality in patients with heart failure: Vesnarinone Study Group. N Engl J Med 1993;329:149-55.
8. Packer M. The development of positive inotropic agents for chronic heart failure: how have we gone astray? J Am Coll Cardiol 1993; 22:119A-26A.
9. Liang C, Lon PD, Sherman G, et al. Sustained improvement of cardiac function in patients with congestive heart failure after short term infusion of dobutamine. Circulation 1984;169:113-9.
10. Unverferth DV, Magorien RD, Altschuld R, et al. The hemodynamic and metabolic advantages gained by a 3-day infusion of dobutamine in patients with congestive cardiomyopathy. Am Heart J 1983; 1106:29-34.
11. Unverferth DV, Blanford M, Kates RE, et al. Tolerance to dobutamine after a 72-hour continuous infusion. Am Heart J 1980;169:262-6.
12. Hodgson JM, Aja M, Sorkin RP. Intermittent ambulatory dobutamine infusion for patients awaiting cardiac transplantation. Am J Cardiol 1984;15:374-5.
13. Berger M, McSherry CK. Outpatients dobutamine infusion: a totally implantable infusion pump for refractory congestive heart failure. Chest 1985;88:295-6.
14. Roffman DS, Applefeld MM, Grove WR, et al. Intermittent dobutamine hydrochloride infusion in outpatients with chronic congestive heart failure. Clin Pharmacol 1985;4:195-9.
15. Krell MJ, Kline EM, Bates ER, et al. Intermittent ambulatory dobutamine infusion in patients with severe congestive heart failure. Am Heart J 1986;112:787-91.
16. Applefeld MN, Newman KA, Sutton FJ, et al. Outpatient dobutamine infusion in the management of chronic heart failure: clinical experience in 21 patients. Am Heart J 1987;1114:589-95.
17. Unverferth DV, Magorien RD, Altschuld R, et al. The hemodynamic and metabolic advantages gained by a 3-day infusion of dobutamine in patients with congestive cardiomyopathy. Am Heart J 1983; 1106:29-34.
18. Dies F, Krell MJ, Whitlow P, et al. Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure. Circulation 1986; 74(suppl II):II-38.
19. Miller LW. Outpatient dobutamine for refractory congestive heart failure: advantages, techniques, and results. J Heart Lung Transplant 1991;10:482-7.
20. Miller LW, Merkle RN, Jennison SH. Outpatient use of dobutamine to support patients awaiting heart transplantation. J Heart Lung Transplant 1994;113:S126-9.
21. Marius Nunez A, Heaney L, Fernandez RN, et al. Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure. Am Heart J 1996;132:805-8.